Antibody-drug conjugates, evolving HER2 guidelines, and biomarker-driven treatment decisions are transforming breast cancer care and expanding the oncology pharmacist’s role.
Allison Reed, pharmD, BCPS, BCOP
Advertisement
Articles by Allison Reed, pharmD, BCPS, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
2
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
3
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
4
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
5